These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38906477)

  • 21. Impact of academic facility type and volume on post-surgical outcomes following diagnosis of glioblastoma.
    Hauser A; Dutta SW; Showalter TN; Sheehan JP; Grover S; Trifiletti DM
    J Clin Neurosci; 2018 Jan; 47():103-110. PubMed ID: 29113851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Addition of chemotherapy to hypofractionated radiotherapy for glioblastoma: practice patterns, outcomes, and predictors of survival.
    Haque W; Verma V; Butler EB; Teh BS
    J Neurooncol; 2018 Jan; 136(2):307-315. PubMed ID: 29090416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors associated with the refusal of surgery and the associated impact on survival in patients with rectal cancer using the National Cancer Database.
    Coffman AR; Tao R; Cohan JN; Huang LC; Pickron TB; Torgeson AM; Lloyd S
    J Gastrointest Oncol; 2021 Aug; 12(4):1482-1497. PubMed ID: 34532104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Consequences of Refusing Surgery for Esophageal Cancer: A National Cancer Database Analysis.
    Rahouma M; Harrison S; Kamel M; Nasar A; Lee B; Port J; Altorki N; Stiles B
    Ann Thorac Surg; 2018 Nov; 106(5):1476-1483. PubMed ID: 30055137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patterns of care and predictors of adjuvant therapies in elderly patients with glioblastoma: An analysis of the National Cancer Data Base.
    Amsbaugh MJ; Yusuf MB; Gaskins J; Burton EC; Woo SY
    Cancer; 2017 Sep; 123(17):3277-3284. PubMed ID: 28452053
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment patterns and outcomes for cerebellar glioblastoma in the concomitant chemoradiation era: A National Cancer database study.
    Zhang M; Li R; Pollom EL; Amini A; Dandapani S; Li G
    J Clin Neurosci; 2020 Dec; 82(Pt A):122-127. PubMed ID: 33317719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complementary Medicine, Refusal of Conventional Cancer Therapy, and Survival Among Patients With Curable Cancers.
    Johnson SB; Park HS; Gross CP; Yu JB
    JAMA Oncol; 2018 Oct; 4(10):1375-1381. PubMed ID: 30027204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes and Patterns of Care in Elderly Patients with Glioblastoma Multiforme.
    Nunna RS; Khalid SI; Patel S; Sethi A; Behbahani M; Mehta AI; Adogwa O; Byrne RW
    World Neurosurg; 2021 May; 149():e1026-e1037. PubMed ID: 33482415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patterns of care and outcomes of chemoradiation versus radiation alone for MGMT promoter unmethylated glioblastoma.
    Lee A; Malakhov N; Sheth N; Wang A; Han P; Schreiber D
    Clin Neurol Neurosurg; 2018 Jul; 170():127-131. PubMed ID: 29777945
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Geographic disparities in access to glioblastoma treatment based on Hispanic ethnicity in the United States: Insights from a national database.
    Lu VM; Shah AH; Eichberg DG; Quinones-Hinojosa A; Esquenazi Y; Komotar RJ; Ivan ME
    J Neurooncol; 2020 May; 147(3):711-720. PubMed ID: 32236779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. More than treatment refusal: a National Cancer Database analysis of adjuvant treatment refusal and racial survival disparities among women with endometrial cancer.
    Barrington DA; Sinnott JA; Nixon D; Padamsee TJ; Cohn DE; Doll KM; Donneyong MM; Felix AS
    Am J Obstet Gynecol; 2022 Aug; 227(2):244.e1-244.e17. PubMed ID: 35283091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concurrent chemoradiotherapy versus radiotherapy alone for "biopsy-only" glioblastoma multiforme.
    Kole AJ; Park HS; Yeboa DN; Rutter CE; Corso CD; Aneja S; Lester-Coll NH; Mancini BR; Knisely JP; Yu JB
    Cancer; 2016 Aug; 122(15):2364-70. PubMed ID: 27172136
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of Sociodemographic Factors on Treatment Decisions in Non-Small-Cell Lung Cancer.
    Duma N; Idossa DW; Durani U; Frank RD; Paludo J; Westin G; Lou Y; Mansfield AS; Adjei AA; Go RS; Ailawadhi S
    Clin Lung Cancer; 2020 May; 21(3):e115-e129. PubMed ID: 31570228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adult cerebellar glioblastoma: understanding survival and prognostic factors using a population-based database from 1973 to 2009.
    Adams H; Chaichana KL; Avendaño J; Liu B; Raza SM; Quiñones-Hinojosa A
    World Neurosurg; 2013 Dec; 80(6):e237-43. PubMed ID: 23395851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patients With Invasive Breast Cancer Who Refuse Treatment: An Analysis of Associated Factors and Impact on Survival.
    Moya JJ; Moazzez A; Ozao-Choy JJ; Dauphine C
    Am Surg; 2021 Dec; 87(10):1627-1632. PubMed ID: 34132121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of concurrent chemotherapy with radiation therapy for elderly patients with newly diagnosed glioblastoma: a review of the National Cancer Data Base.
    Huang J; Samson P; Perkins SM; Ansstas G; Chheda MG; DeWees TA; Tsien CI; Robinson CG; Campian JL
    J Neurooncol; 2017 Feb; 131(3):593-601. PubMed ID: 27844308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A National Cancer Disparities Analysis of Predictors for Radiation Therapy Refusal by Race.
    Taparra K; Qu V; Lau B; Pollom E
    Int J Radiat Oncol Biol Phys; 2023 May; 116(1):96-102. PubMed ID: 36764491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical features associated with the efficacy of chemotherapy in patients with glioblastoma (GBM): a surveillance, epidemiology, and end results (SEER) analysis.
    Wen J; Chen W; Zhu Y; Zhang P
    BMC Cancer; 2021 Jan; 21(1):81. PubMed ID: 33468109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Refusal of surgery for colon cancer: Sociodemographic disparities and survival implications among US patients with resectable disease.
    Alty IG; Dee EC; Cusack JC; Blaszkowsky LS; Goldstone RN; Francone TD; Wo JY; Qadan M
    Am J Surg; 2021 Jan; 221(1):39-45. PubMed ID: 32723488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A population-based propensity score matching analysis of risk factors and the impact on survival associated with refusal of cancer-directed surgery in patients with prostate cancer.
    Tang Y; Gao Y; Zhang R; Li T; Yang Y; Huang L; Wei Y
    Sci Rep; 2024 Apr; 14(1):9494. PubMed ID: 38664545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.